Search Results

By Sarah L. Sammons, MD, and Nancy U. Lin, MD  / October 10, 2022 - Supplement: Breast Cancer Almanac

Breast Cancer 2021–2022 Almanac

The past year has seen an unprecedented number of practice-changing advances across all three major breast cancer subtypes. For patients with early-stage triple-negative breast cancer, neoadjuvant chemotherapy plus pembrolizumab firmly entered the standard of care based on improvements in...